Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
Infectious diseases remain one of the leading causes of morbidity and mortality worldwide. The WHO and CDC have expressed serious concern regarding the continued increase in the development of multidrug resistance among bacteria. Therefore, the antibiotic resistance crisis is one of the most pressin...
Main Authors: | Pedro V. Baptista, Matthew P. McCusker, Andreia Carvalho, Daniela A. Ferreira, Niamh M. Mohan, Marta Martins, Alexandra R. Fernandes |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2018.01441/full |
Similar Items
-
Unlocking NuriPep 1653 From Common Pea Protein: A Potent Antimicrobial Peptide to Tackle a Pan-Drug Resistant Acinetobacter baumannii
by: Niamh Maire Mohan, et al.
Published: (2019-09-01) -
Prevalence and multidrug resistance of Enterococcus species isolated from chickens at slaughterhouses in Nakhon Ratchasima Province, Thailand
by: Pattarakitti Noenchat, et al.
Published: (2022-11-01) -
Rational Framework for the Design of Trp- and Arg-Rich Peptide Antibiotics Against Multidrug-Resistant Bacteria
by: Wenyu Xiang, et al.
Published: (2022-05-01) -
Editorial: Alternative Therapeutics Against Antimicrobial-Resistant Pathogens
by: Rebecca Thombre, et al.
Published: (2019-09-01) -
Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria
by: Kaitlin S. Witherell, et al.
Published: (2020-09-01)